MPO and cystic fibrosis: This is consistent with our prior findings that RLS-0071 can inhibit MPO oxidative activity utilizing purified MPO in vitro [36], in CF sputum samples ex vivo [35] and inhibit MPO-triggered NET formation in vitro [39].